Anna Kurzeja
YOU?
Author Swipe
View article: A European perspective on tardive dyskinesia
A European perspective on tardive dyskinesia Open
Tardive dyskinesia (TD) is a medication-induced movement disorder associated with long-term use of dopamine receptor-blocking agents, most frequently antipsychotics. Its clinical presentation comprises involuntary hyperkinetic movements of…
View article: Glatiramer Acetate Or IFN-β Bridging Therapy in Women With Relapsing Multiple Sclerosis Planning a Pregnancy
Glatiramer Acetate Or IFN-β Bridging Therapy in Women With Relapsing Multiple Sclerosis Planning a Pregnancy Open
Aim: To assess bridging glatiramer acetate (GA) or IFN-β for relapse prevention in women with relapsing multiple sclerosis planning pregnancy. Materials & methods: Participants discontinued disease-modifying therapies (DMTs) and received G…
View article: Safety evaluations of offspring breastfed by mothers receiving glatiramer acetate for relapsing multiple sclerosis
Safety evaluations of offspring breastfed by mothers receiving glatiramer acetate for relapsing multiple sclerosis Open
GA treatment of mothers with RMS during breastfeeding did not increase AEs, hospitalisations or antibiotic use in their offspring versus control offspring. These data support previous COBRA data that the benefit of maternal RMS treatment w…
View article: Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA study
Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA study Open
Background: Safety data on disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) during breastfeeding are limited. Objective: Assess safety outcomes for offspring breastfed by mothers undergoing glatiramer acetate (GA; …
View article: Patient adherence to and tolerability of treatment with metformin extended-release formulation in patients with type 2 diabetes. GLUCOMP study
Patient adherence to and tolerability of treatment with metformin extended-release formulation in patients with type 2 diabetes. GLUCOMP study Open
Introduction. Appropriate treatment of diabetes requires regular intake of recommended drugs. Multifactorial therapy, which necessitates the concomitant use of many medications, may decrease patient adherence. The purpose of the study was …